Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | PRNP | P04156 | 2/20 | 0.44 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | PPARA | Q07869 | 5/20 | 0.35 |
| ▸ | TYMP | P19971 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6166784 | 0.74 | — | — | |
| SCHEMBL15583393 | 0.72 | KDM4E (0.70) | KDM4ELMNAALDH1A1RXFP1NPSR1 | |
| SCHEMBL11024816 | 0.68 | ALDH1A1 (0.44) | KDM4ELMNAALDH1A1RXFP1NPSR1 | |
| SCHEMBL6164956 | 0.67 | KIF11 (0.37) | ALDH1A1HSD17B10 | |
| SCHEMBL19876885 | 0.67 | MEN1 (0.35) | KDM4ELMNAALDH1A1HSD17B10SMN1; SMN2 | |
| SCHEMBL16543222 | 0.64 | KDM4E (0.59) | KDM4ELMNAALDH1A1RXFP1NPSR1 | |
| SCHEMBL10829734 | 0.63 | TYMP (0.43) | KDM4ELMNAALDH1A1RXFP1NPSR1 | |
| SCHEMBL6161347 | 0.63 | CA12 (0.56) | LMNAALDH1A1RXFP1NPSR1PRNP | |
| SCHEMBL10691578 | 0.63 | ALDH1A1 (0.63) | KDM4ELMNAALDH1A1HSD17B10SMN1; SMN2 | |
| SCHEMBL24890374 | 0.61 | KDM4E (0.35) | KDM4EALDH1A1HSD17B10SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0934310-B1 | THIO ACID DERIVED MONOCYCLIC N-HETEROCYCLICS AS ANTICOAGULANTS | SCHERING AG (DE) | 2005-02-09 | — | — | EP | disclosed |
| US-6221886-B1 | Thio acid derived monocyclic N-heterocyclics as anticoagulants | BERLEX LABORATORIES, INC. | 2001-04-24 | — | — | US | disclosed |
| US-6166014-A | Thio acid derived monocyclic N-heterocyclics as anticoagulants | BERLEX LABORATORIES, INC. (US) | 2000-12-26 | — | — | US | disclosed |
| US-6162807-A | Thio acid derived monocyclic N-heterocyclics as anticoagulants | BERLEX LABORATORIES, INC. (US) | 2000-12-19 | — | — | US | disclosed |
| US-6150382-A | ENZYME INHIBITORS OF BLOOD COAGULATION FACTOR XA, A SERINE PROTEASE CLASS OF ENZYMES; E.G., 4-HYDROXY-3-((4-(2-CARBOXY-METHYL)THIO-6-(3-(1-METHYL)-6-(3-(1 -METHYL)IMIDAZOLIN-2-YL)-PHENOXY-3,5-DIFLUOROPYRIDINE AND DERIVATIVES | BERLEX LABORATORIES, INC. (US) | 2000-11-21 | — | — | US | disclosed |
| US-6034084-A | CARDIOVASCULAR DISORDERS | BERLEX LABORATORIES, INC. (US) | 2000-03-07 | — | — | US | disclosed |
| US-6004985-A | BLOOD-COAGULATION FACTOR XA INHIBITORS | BERLEX LABORATORIES, INC. (US) | 1999-12-21 | — | — | US | disclosed |
| EP-0934310-A1 | THIO ACID DERIVED MONOCYCLIC $i(N)-HETEROCYCLICS AS ANTICOAGULANTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-08-11 | — | — | EP | disclosed |
| WO-1998015547-A1 | THIO ACID DERIVED MONOCYCLIC N-HETEROCYCLICS AS ANTICOAGULANTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-04-16 | — | — | WO | disclosed |